Found 1375 matching trials
Radiation Therapy in Unresectable Gall Bladder Cancer PHASE2 The goal of this clinical trial is to compare two treatment regimes, namely...
Show More Location
Tata Memorial Centre
Learn More & Join Trial
Bevacizumab, Doxorubicin, and Cyclophosphamide Followed By Paclitaxel Albumin-Stabilized Nanoparticle Formulation and Bevacizumab in Treating Patients Who Have Undergone Surgery for Early-Stage Breast Cancer NA RATIONALE: Monoclonal antibodies, such as bevacizumab, can block tumor grow...
Show More Location
Memorial Sloan-Kettering Cancer Center
Learn More & Join Trial
Efficacy and Safety of Serplulimab Combined With Chemotherapy as Neoadjuvant Treatment for Locally Advanced Gastric Cancer or Adenocarcinoma of Esophagogastric Junction PHASE2 This is a multicenter, double-blind, randomized, phase 2 trial to investiga...
Show More Location
The fourth hospital of Hebei Medical University
Learn More & Join Trial
First-line Therapy in Metastatic PDAC PHASE2 The overarching hypothesis of this trial is that the NAPOLI regimen and alt...
Show More Location
Klinikum der Universitaet Muenchen - Campus Grosshadern
Learn More & Join Trial
Study of Adjuvant Nimotuzumab Combined with Nab-paclitaxel+ Gemcitabine in EGFR-positive Pancreatic Cancer PHASE2 This is a prospective, single-arm trial. The main purpose of the study is t...
Show More Location
Zhejiang Provincial People's Hospital
Learn More & Join Trial
Observational Study on Quality of Life of Patients Receiving Nab-paclitaxel/Gemcitabine First Line Therapy, Including a Translational Program N/A Current studies resulted in a superiority of a combination of nab-paclitaxe...
Show More Location
Krankenhaus Nordwest gGmbH - Institute of Clinical Cancer Research
Learn More & Join Trial
Gemcitabine Hydrochloride, Cisplatin, Nab-Paclitaxel, and Durvalumab in Treating Patients With Locally Advanced or Metastatic Gallbladder Cancer PHASE2 This phase II trail will evaluate the efficacy and safety of combining gemc...
Show More Location
Hepatobiliary Surgery Center, Department of General Surgery, Huashan Hospital & Cancer Metastasis Institute, Fudan University
Learn More & Join Trial
A Study of Donafenib Plus S-1 in Treating Patients With Metastatic Pancreatic Cancer After Chemotherapy With Nab-paclitaxel Plus Gemcitabine Regimen PHASE2 This is a single arm, open label Phase II clinical trial to evaluate the ef...
Show More Learn More & Join Trial
Surgery vs. Radical Chemoradiotherapy for Esophageal SCC After Neoadjuvant Immunochemotherapy PHASE3 This is a Phase III, multicenter, open-label, randomized controlled trial. ...
Show More Location
Henan Cancer Hospital
Learn More & Join Trial
Pancreatic Adenocarcinoma Neoadjuvant Chemotherapy Before Surgery PHASE2 This is a single-arm, single-center feasibility trial of patients with bord...
Show More Location
Juravinski Hospital
Learn More & Join Trial